| Product Code: ETC13261049 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Africa Infectious Disease Drug Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa Infectious Disease Drug Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa Infectious Disease Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Africa Infectious Disease Drug Market - Industry Life Cycle |
3.4 Africa Infectious Disease Drug Market - Porter's Five Forces |
3.5 Africa Infectious Disease Drug Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Africa Infectious Disease Drug Market Revenues & Volume Share, By Source Type, 2021 & 2031F |
3.7 Africa Infectious Disease Drug Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.8 Africa Infectious Disease Drug Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.9 Africa Infectious Disease Drug Market Revenues & Volume Share, By Mode of Action Type, 2021 & 2031F |
3.10 Africa Infectious Disease Drug Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.11 Africa Infectious Disease Drug Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.12 Africa Infectious Disease Drug Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Africa Infectious Disease Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa Infectious Disease Drug Market Trends |
6 Africa Infectious Disease Drug Market, 2021 - 2031 |
6.1 Africa Infectious Disease Drug Market, Revenues & Volume, By Source Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Africa Infectious Disease Drug Market, Revenues & Volume, By Bacterial Diseases, 2021 - 2031 |
6.1.3 Africa Infectious Disease Drug Market, Revenues & Volume, By Virusal Diseases, 2021 - 2031 |
6.1.4 Africa Infectious Disease Drug Market, Revenues & Volume, By Fungal Disease, 2021 - 2031 |
6.1.5 Africa Infectious Disease Drug Market, Revenues & Volume, By Parasitic Disease, 2021 - 2031 |
6.2 Africa Infectious Disease Drug Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Africa Infectious Disease Drug Market, Revenues & Volume, By Jaundice, 2021 - 2031 |
6.2.3 Africa Infectious Disease Drug Market, Revenues & Volume, By Leprosy, 2021 - 2031 |
6.2.4 Africa Infectious Disease Drug Market, Revenues & Volume, By Listeria, 2021 - 2031 |
6.2.5 Africa Infectious Disease Drug Market, Revenues & Volume, By Lyme Disease, 2021 - 2031 |
6.2.6 Africa Infectious Disease Drug Market, Revenues & Volume, By Malaria, 2021 - 2031 |
6.2.7 Africa Infectious Disease Drug Market, Revenues & Volume, By Measles, 2021 - 2031 |
6.2.8 Africa Infectious Disease Drug Market, Revenues & Volume, By Molluscum Contagiosum, 2021 - 2031 |
6.2.9 Africa Infectious Disease Drug Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Africa Infectious Disease Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Africa Infectious Disease Drug Market, Revenues & Volume, By Medication, 2021 - 2031 |
6.3.3 Africa Infectious Disease Drug Market, Revenues & Volume, By Dietary Supplements, 2021 - 2031 |
6.3.4 Africa Infectious Disease Drug Market, Revenues & Volume, By Surgery, 2021 - 2031 |
6.4 Africa Infectious Disease Drug Market, Revenues & Volume, By Mode of Action Type, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Africa Infectious Disease Drug Market, Revenues & Volume, By Antibacterial Drugs, 2021 - 2031 |
6.4.3 Africa Infectious Disease Drug Market, Revenues & Volume, By Antiviral Drugs, 2021 - 2031 |
6.4.4 Africa Infectious Disease Drug Market, Revenues & Volume, By Antifungal Drugs, 2021 - 2031 |
6.4.5 Africa Infectious Disease Drug Market, Revenues & Volume, By Antiparasitic Drugs, 2021 - 2031 |
6.5 Africa Infectious Disease Drug Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Africa Infectious Disease Drug Market, Revenues & Volume, By Tafenoquine, 2021 - 2031 |
6.5.3 Africa Infectious Disease Drug Market, Revenues & Volume, By Omadacycline, 2021 - 2031 |
6.5.4 Africa Infectious Disease Drug Market, Revenues & Volume, By Tecovirimat, 2021 - 2031 |
6.5.5 Africa Infectious Disease Drug Market, Revenues & Volume, By Eravacycline, 2021 - 2031 |
6.5.6 Africa Infectious Disease Drug Market, Revenues & Volume, By Delafloxacin, 2021 - 2031 |
6.5.7 Africa Infectious Disease Drug Market, Revenues & Volume, By Plazomicin, 2021 - 2031 |
6.5.8 Africa Infectious Disease Drug Market, Revenues & Volume, By Benznidazole, 2021 - 2031 |
6.5.9 Africa Infectious Disease Drug Market, Revenues & Volume, By Others, 2021 - 2031 |
6.6 Africa Infectious Disease Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 Africa Infectious Disease Drug Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.6.3 Africa Infectious Disease Drug Market, Revenues & Volume, By Topical, 2021 - 2031 |
6.6.4 Africa Infectious Disease Drug Market, Revenues & Volume, By Intravenous, 2021 - 2031 |
6.7 Africa Infectious Disease Drug Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.7.1 Overview & Analysis |
6.7.2 Africa Infectious Disease Drug Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.7.3 Africa Infectious Disease Drug Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.7.4 Africa Infectious Disease Drug Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.7.5 Africa Infectious Disease Drug Market, Revenues & Volume, By Others, 2021 - 2031 |
7 Africa Infectious Disease Drug Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Africa Infectious Disease Drug Market, Revenues & Volume, By Source Type, 2021 - 2031 |
7.2.1 South Africa Infectious Disease Drug Market, Revenues & Volume, By Source Type, 2021 - 2031 |
7.2.2 Egypt Infectious Disease Drug Market, Revenues & Volume, By Source Type, 2021 - 2031 |
7.2.3 Nigeria Infectious Disease Drug Market, Revenues & Volume, By Source Type, 2021 - 2031 |
7.2.4 Rest of Africa Infectious Disease Drug Market, Revenues & Volume, By Source Type, 2021 - 2031 |
7.3 Africa Infectious Disease Drug Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
7.3.1 South Africa Infectious Disease Drug Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.3.2 Egypt Infectious Disease Drug Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.3.3 Nigeria Infectious Disease Drug Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.3.4 Rest of Africa Infectious Disease Drug Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.4 Africa Infectious Disease Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.4.1 South Africa Infectious Disease Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.4.2 Egypt Infectious Disease Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.4.3 Nigeria Infectious Disease Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.4.4 Rest of Africa Infectious Disease Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.5 Africa Infectious Disease Drug Market, Revenues & Volume, By Mode of Action Type, 2021 - 2031 |
7.5.1 South Africa Infectious Disease Drug Market, Revenues & Volume, By Mode of Action Type, 2021 - 2031 |
7.5.2 Egypt Infectious Disease Drug Market, Revenues & Volume, By Mode of Action Type, 2021 - 2031 |
7.5.3 Nigeria Infectious Disease Drug Market, Revenues & Volume, By Mode of Action Type, 2021 - 2031 |
7.5.4 Rest of Africa Infectious Disease Drug Market, Revenues & Volume, By Mode of Action Type, 2021 - 2031 |
7.6 Africa Infectious Disease Drug Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.6.1 South Africa Infectious Disease Drug Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.6.2 Egypt Infectious Disease Drug Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.6.3 Nigeria Infectious Disease Drug Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.6.4 Rest of Africa Infectious Disease Drug Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.7 Africa Infectious Disease Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.7.1 South Africa Infectious Disease Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.7.2 Egypt Infectious Disease Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.7.3 Nigeria Infectious Disease Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.7.4 Rest of Africa Infectious Disease Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.8 Africa Infectious Disease Drug Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.8.1 South Africa Infectious Disease Drug Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.8.2 Egypt Infectious Disease Drug Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.8.3 Nigeria Infectious Disease Drug Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.8.4 Rest of Africa Infectious Disease Drug Market, Revenues & Volume, By End-Users, 2021 - 2031 |
8 Africa Infectious Disease Drug Market Key Performance Indicators |
9 Africa Infectious Disease Drug Market - Export/Import By Countries Assessment |
10 Africa Infectious Disease Drug Market - Opportunity Assessment |
10.1 Africa Infectious Disease Drug Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Africa Infectious Disease Drug Market Opportunity Assessment, By Source Type, 2021 & 2031F |
10.3 Africa Infectious Disease Drug Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
10.4 Africa Infectious Disease Drug Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
10.5 Africa Infectious Disease Drug Market Opportunity Assessment, By Mode of Action Type, 2021 & 2031F |
10.6 Africa Infectious Disease Drug Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
10.7 Africa Infectious Disease Drug Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10.8 Africa Infectious Disease Drug Market Opportunity Assessment, By End-Users, 2021 & 2031F |
11 Africa Infectious Disease Drug Market - Competitive Landscape |
11.1 Africa Infectious Disease Drug Market Revenue Share, By Companies, 2022 |
11.2 Africa Infectious Disease Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here